Clinical trials recruiting for Metastatic Gastric Cancer
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| NKT3964 | 1 |
| p95HER2.CAR-TECH2Me | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Arkansas | 1 |
| California | 1 |
| Colorado | 1 |
| Florida | 1 |
| Georgia | 1 |
| Kansas | 1 |
| Massachusetts | 1 |
| New Jersey | 1 |
| Pennsylvania | 1 |
| Tennessee | 1 |
| Texas | 1 |
| Utah | 1 |
Top cities
Self-screener
Recruiting trials
- A Phase I Interventional Open-label, Non-randomized Dose-escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Preliminary Anti-tumor Activity of Autologous p95HER2.CAR-TECH2Me T Cells in Patients With Selected Advanced Cancers.
- A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- Liver Embolization Approaches for Tumor Management
Related conditions
Trials recruiting for Metastatic Gastric Cancer often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Metastatic Gastric Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.